SOX21-AS1: A Potential Drug Target and Biomarker (G100507533)

Target Name: SOX21-AS1

NCBI ID: G100507533

SOX21-AS1

Other Name(s): SOX21 antisense divergent transcript 1

SOX21-AS1: A Potential Drug Target and Biomarker

The SOX21 gene is located on chromosome 1p36 and encodes for the transcription factor SOX21-AS1, which plays a crucial role in the development and maintenance of tissues and organs, including the nervous system and heart. SOX21-AS1 has been shown to participate in several cellular processes that are involved in cancer progression and Angioimmunological diseases, such as autoimmune neurodegeneration and neuroinflammation.

Despite the promising findings of SOX21-AS1's involvement in these processes, much research is still needed to fully understand its role in disease and to identify potential drug targets. One potential drug target for SOX21-AS1 is the inhibition of its activity, which could lead to new treatments for a variety of Angioimmunological diseases.

The Potential Role of SOX21-AS1 in Cancer Progression

SOX21-AS1 has been shown to contribute to the development and progression of several types of cancer, including breast, ovarian, and prostate cancers. In breast cancer, SOX21-AS1 has been shown to promote the growth and survival of cancer cells and to inhibit the efficacy of anti-cancer drugs.

One of the mechanisms through which SOX21-AS1 contributes to cancer progression is its role in the regulation of cell signaling pathways, including the TGF-β pathway. TGF-β is a critical signaling pathway involved in cell growth, differentiation, and survival, and has been implicated in the development and progression of many types of cancer.

In addition to its role in TGF-β signaling, SOX21-AS1 has also been shown to contribute to the development of cancer by promoting the activation and maintenance of oncogenic signaling pathways, such as the PI3K/Akt pathway. This pathway is involved in the regulation of cell survival and growth, and has been implicated in the development and progression of many types of cancer.

The Potential Role of SOX21-AS1 in Neurodegenerative Diseases

SOX21-AS1 has also been shown to play a role in the development and progression of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. These conditions are characterized by the progressive loss of brain cells and the development of neurofibrillary tangles, which are thought to contribute to the symptoms of these conditions.

One of the mechanisms through which SOX21-AS1 contributes to neurodegenerative diseases is its role in the regulation of cellular processes that are involved in the formation and maintenance of neurofibrillary tangles. neurofibrillary tangles are composed of abnormal aggregates of the protein tau, which are thought to play a role in the formation and progression of neurodegenerative diseases.

In addition to its role in neurofibrillary tangles, SOX21-AS1 has also been shown to contribute to the development and progression of neurodegenerative diseases by promoting the activation and maintenance of oncogenic signaling pathways, such as the TGF-β pathway. This pathway is involved in the regulation of cell survival and growth, and has been implicated in the development and progression of many types of neurodegenerative diseases.

The Potential Role of SOX21-AS1 in Autoimmune Neurodegeneration

Autoimmune neurodegeneration is a condition in which the immune system attacks and destroys the brain cells and nervous system. This condition is characterized by a range of symptoms, including progressive muscle weakness, vision problems, and cognitive decline.

One of the mechanisms through which SOX21-AS1 contributes to autoimmune neurodegeneration is its role in the regulation of cellular processes that are involved in the immune response. In addition to its role in TGF-β signaling, SOX21-AS1 has also been shown to contribute to the development and progression of autoimmune neurodegeneration by promoting the activation and maintenance of oncogenic signaling pathways, such as the

Protein Name: SOX21 Antisense Divergent Transcript 1

The "SOX21-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SOX21-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets